In Vitro Interaction between Cefixime and Amoxicillin-Clavulanate against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Causing Urinary Tract Infection-Reference-Cited by-同舟云学术

In Vitro Interaction between Cefixime and Amoxicillin-Clavulanate against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Causing Urinary Tract Infection

Published:2012-04-25 Issue:7 Volume:50 Page:2540-2541
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:Journal of Clinical Microbiology

Author:

Bingen E.,Bidet P.,Birgy A.,Sobral E.,Mariani P.,Cohen R.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference12 articles.

1. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients;Balke;Eur. J. Clin. Microbiol. Infect. Dis.,2006

2. Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children;Bocquet;Pediatrics,2012

3. New in vitro models for studying antibiotic combination using predefined antibiotics gradient, abstr 011;Bolstrom,1989

4. Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of ESBL-producing members of the Enterobacteriaceae;Campbell;J. Clin. Microbiol.,2012

5. Performance standards for antimicrobial susceptibility testing, 20th informational supplement. M100-S21;Clinical and Laboratory Standards Institute,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiothérapies curatives des infections urinaires de l’enfant;Journal de Pédiatrie et de Puériculture;2024-06

2. Uropathogenic Escherichia coli in urinary tract infections;Molecular Medical Microbiology;2024

3. Antimicrobial treatment of urinary tract infections in children;Infectious Diseases Now;2023-11

4. Bio‐Based Anti‐Biofoulant with Copper(II) as Intramolecular Catalyst for Radicals Formation;Advanced Materials Interfaces;2023-03-02

5. In Vitro and In Vivo Activity of Amoxicillin–Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae;Microbial Drug Resistance;2022-04-01